Frank Ruffo - Net Worth and Insider Trading
Frank Ruffo Net Worth
The estimated net worth of Frank Ruffo is at least $203,902 dollars as of 2024-06-08. Frank Ruffo is the CFO of Aclaris Therapeutics Inc and owns about 201,883 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $203,902. Details can be seen in Frank Ruffo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank Ruffo has not made any transactions after 2022-03-10 and currently still holds the listed stock(s).
Transaction Summary of Frank Ruffo
Frank Ruffo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Ruffo owns 1 companies in total, including Aclaris Therapeutics Inc (ACRS) .
Click here to see the complete history of Frank Ruffo’s form 4 insider trades.
Insider Ownership Summary of Frank Ruffo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2022-03-10 | Chief Financial Officer |
Frank Ruffo Latest Holdings Summary
Frank Ruffo currently owns a total of 1 stock. Frank Ruffo owns 201,883 shares of Aclaris Therapeutics Inc (ACRS) as of March 10, 2022, with a value of $203,902.
Latest Holdings of Frank Ruffo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2022-03-10 | 201,883 | 1.01 | 203,902 |
Holding Weightings of Frank Ruffo
Frank Ruffo Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Ruffo has made a total of 3 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 12,823 shares on March 10, 2022, which brought Frank Ruffo around $199,398.
Insider Trading History of Frank Ruffo
- 1
Frank Ruffo Trading Performance
GuruFocus tracks the stock performance after each of Frank Ruffo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Ruffo is 9.89%. GuruFocus also compares Frank Ruffo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Ruffo within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank Ruffo's insider trading performs compared to the benchmark.
Performance of Frank Ruffo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.37 | | | | | |
| Relative Return to S&P 500(%) | 2.41 | | | | | |
Frank Ruffo Ownership Network
Frank Ruffo Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Frank Ruffo is the Chief Financial Officer of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Frank Ruffo made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 189,238 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 152,243 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Frank Ruffo Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Ruffo. You might contact Frank Ruffo via mailing address: C/o Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
